James Hippel
Finanzdirektor/CFO bei BIO-TECHNE CORPORATION
Vermögen: 5 Mio $ am 30.04.2024
Profil
Derzeit bekleidet James T. Hippel die Position des CFO & Principal Accounting Officer der Bio-Techne Corp. und des Chief Financial Officer von ProteinSimple (einer Tochtergesellschaft der Bio-Techne Corp.). In der Vergangenheit war Herr Hippel Chief Financial Officer & Senior Vice President bei Mirion Technologies, Inc. und Vice President-Finance bei Thermo Fisher Scientific, Inc. sowie Principal bei Honeywell International, Inc. und Principal bei KPMG Peat Marwick LLP. Er erhielt einen MBA von der Arizona State University und einen Bachelor-Abschluss von der Northern Arizona University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
BIO-TECHNE CORPORATION
0,05% | 19.12.2023 | 71 884 ( 0,05% ) | 5 Mio $ | 30.04.2024 |
Aktive Positionen von James Hippel
Unternehmen | Position | Beginn |
---|---|---|
BIO-TECHNE CORPORATION | Finanzdirektor/CFO | 01.04.2014 |
ProteinSimple
ProteinSimple Medical SpecialtiesHealth Technology ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA. | Finanzdirektor/CFO | - |
Bio-Techne
Bio-Techne Medical SpecialtiesHealth Technology Bio-Techne is a life sciences company founded in 1981 that provides innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company is based in Devens, MA. The company's products aid in scientific investigations into biological processes and the nature and progress of specific diseases, drug discovery efforts, and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.10 billion in net sales in fiscal 2023 and has approximately 3,200 employees worldwide. | Direktor/Vorstandsmitglied | - |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von James Hippel
Unternehmen | Position | Ende |
---|---|---|
Mirion Technologies (US), Inc.
Mirion Technologies (US), Inc. Electronic Equipment/InstrumentsElectronic Technology Mirion Technologies (US), Inc. engages in the provision of nuclear measurement and detection systems. It offers measurement and enterprise, calibration, customer training programs, installation, product support and repairs, consulting, and instadose dosimetry services. The company was founded in December 2005 and is headquartered in San Ramon, CA. | Finanzdirektor/CFO | 01.03.2014 |
THERMO FISHER SCIENTIFIC | Finanzdirektor/CFO | 01.04.2012 |
KPMG Peat Marwick LLP | Corporate Officer/Principal | - |
HONEYWELL INTERNATIONAL INC. | Corporate Officer/Principal | - |
Ausbildung von James Hippel
Arizona State University | Masters Business Admin |
Northern Arizona University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
THERMO FISHER SCIENTIFIC | Health Technology |
HONEYWELL INTERNATIONAL INC. | Electronic Technology |
BIO-TECHNE CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
KPMG Peat Marwick LLP | Commercial Services |
Mirion Technologies (US), Inc.
Mirion Technologies (US), Inc. Electronic Equipment/InstrumentsElectronic Technology Mirion Technologies (US), Inc. engages in the provision of nuclear measurement and detection systems. It offers measurement and enterprise, calibration, customer training programs, installation, product support and repairs, consulting, and instadose dosimetry services. The company was founded in December 2005 and is headquartered in San Ramon, CA. | Electronic Technology |
ProteinSimple
ProteinSimple Medical SpecialtiesHealth Technology ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA. | Health Technology |
Bio-Techne
Bio-Techne Medical SpecialtiesHealth Technology Bio-Techne is a life sciences company founded in 1981 that provides innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company is based in Devens, MA. The company's products aid in scientific investigations into biological processes and the nature and progress of specific diseases, drug discovery efforts, and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.10 billion in net sales in fiscal 2023 and has approximately 3,200 employees worldwide. | Health Technology |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Health Technology |